IP Library Assignment 030495/0443
Patent Assignment
Reel/Frame 030495/0443

Assignment of Assignor's Interest

Recorded: 2013-05-28 Pages: 17
Assignors
ESAU, CHRISTINE
Executed: 2004-08-27
LOLLO, BRIDGET
Executed: 2004-08-27
BENNETT, C. FRANK
Executed: 2004-09-03
FREIER, SUSAN M.
Executed: 2004-08-24
GRIFFEY, RICHARD H.
Executed: 2004-08-24
BAKER, BRENDA F.
Executed: 2004-08-24
VICKERS, TIMOTHY A.
Executed: 2004-09-01
MARCUSSON, ERIC G.
Executed: 2004-08-27
KOLLER, ERICH
Executed: 2004-08-27
SWAYZE, ERIC E.
Executed: 2004-09-07
JAIN, RAVI
Executed: 2004-08-25
BHAT, BALKRISHEN
Executed: 2004-08-27
PERALTA, EIGEN
Executed: 2004-08-25
Assignee
ISIS PHARMACEUTICALS INC.
2292 FARADAY AVENUE, CARLSBAD, CALIFORNIA, 92008
Covered Property (1)
Method of Inhibiting Mir-33 Using a Modified Oligonucleotide
Patent: 8,809,294 →
Application: 13/540,097 →
Publication: US 2012/0283319
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 28, 2013
From: ISIS PHARMACEUTICALS INC.
To: REGULUS THERAPEUTICS, LLC
Reel/Frame 030495/0583 →
Change of Name May 28, 2013
From: REGULUS THERAPEUTICS, LLC
To: REGULUS THERAPEUTICS INC.
Reel/Frame 030498/0602 →
Security Interest Aug 8, 2018
From: REGULUS THERAPEUTICS INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND LENDER
Reel/Frame 046748/0561 →
Release of Security Interest May 14, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND LENDER
To: REGULUS THERAPEUTICS INC.
Reel/Frame 067402/0782 →